FDA Grants Fast Track Designation to Quoin’s QRX003 Lotion for Netherton Syndrome

— Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions with significant unmet ...

March 13, 2026 | Friday | News
Singapore Health Promotion Board Renews Collaboration with CueZen to Scale AI-Driven Preventive Health

Singapore Health Promotion Board Extends Collaboration with CueZen AI After Personalization Helps Millions Lead Healthier Lives CueZen, an AI-...

March 11, 2026 | Wednesday | News
CMIC Co., Ltd. Partners with Bluenote to Deploy Agentic AI Across Clinical Development

CMIC Co., Ltd., a contract research organization (CRO) jointly owned by Blackstone and CMIC HOLDINGS Co. Ltd.,  announced a strategic partnership with...

March 11, 2026 | Wednesday | News
Bayer Secures FDA Clearance Expanding Capabilities of MEDRAD MRXperion MR Injection System

Clearance reinforces Bayer’s continued commitment to dependable, integrated radiology solutions Expanded Tesla compatibility captures low- to ...

March 06, 2026 | Friday | News
Acadia Pharmaceuticals Inc. to Seek Re-Examination Following Negative CHMP Opinion on Trofinetide

Acadia Pharmaceuticals Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) informed the ...

March 04, 2026 | Wednesday | News
Morcamilast Earns EU Orphan Drug Designation for Rare Inflammatory Skin Disease

Meiji Seika Pharma Co., Ltd. announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodieste...

March 04, 2026 | Wednesday | News
Cipla USA Inc. Launches Generic Saxenda® in the U.S., Expanding Access to GLP-1 Weight Management Therapy

Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla")announced the launch of Li...

March 03, 2026 | Tuesday | News
Bayer Advances 225Ac-PSMA-Trillium to Next Phase Following Promising Phase I Data in mCRPC

225Ac-PSMA-Trillium (BAY 3563254) is an investigational targeted alpha therapy (TAT) being developed for patients with advanced metastatic castration...

March 02, 2026 | Monday | News
Designing Decarbonization: Embedding Sustainability at the Core of Life Sciences Infrastructure

As life sciences companies scale biologics, advanced therapies, and personalized medicines, sustainability has moved from aspiration to operational imperat...

March 02, 2026 | Monday | News
Lupin Expands U.S. CNS Portfolio with FDA Approval of Brivaracetam Oral Solution

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN)   announced that it has received ap...

February 26, 2026 | Thursday | News
Abbott Secures Shareholder Approval for Exact Sciences Acquisition in Major Diagnostics Expansion

Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests,  announced th...

February 24, 2026 | Tuesday | News
Rezon Bio Secures U.S. Food and Drug Administration Approval for Commercial Biosimilar Manufacturing at Warsaw-Duchnice Facility

Rezon Bio announces that its Warsaw-Duchnice facility has received approval from the U.S. Food and Drug Administration (FDA) for the commercial manufactu...

February 20, 2026 | Friday | News
Daiichi Sankyo and AstraZeneca Advance ENHERTU Toward EU Approval in Early Breast Cancer Following Landmark Phase 3 Risk Reduction Data

Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-D...

February 20, 2026 | Friday | News
Primera Analytical Solutions Accelerates FDA-Compliant Digital Transformation with Cenevo’s Labguru Platform

Primera Analytical Solutions (Primera), an FDA-compliant analytical Contract Research Organization (CRO), has selected Cenevo’s  Labguru electro...

February 20, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close